"A lack of resources and costly expenses up front have made this model less effective and offered little return on investment. Therefore, pharmaceutical and biotech companies and their partners are well-positioned to adopt an “open source” collaborative approach to partnering and developing innovative market-driven solutions and therapies."
In his State of the Union Speech President Obama called for support for 'the same kind of research that led to the computer chip and the Internet.' He
Add a comment...